Now I have all the necessary information. Let me produce the final consolidated review.

## Summary

The paper proposes EpilepsyFM, a foundation model for epilepsy that works on both scalp EEG and intracranial SEEG signals. The model uses a VQ-VAE-style neural tokenizer trained on both modalities, three parallel encoders (temporal, spectral, spatial) to capture seizure propagation dynamics, and a channel set masking pre-training strategy motivated by clustered neuronal discharge mechanisms. Evaluated on seizure detection and short/long-term signal prediction across up to five datasets (including private hospital data), EpilepsyFM consistently outperforms self-supervised EEG baselines (TF-C, SimMTM, BrainBERT, LaBraM) and one supervised EEG transformer.

## Strengths

1. **Consistent outperformance of relevant self-supervised baselines across multiple tasks and modalities.** On TUAB detection, EpilepsyFM achieves 86.2% balanced accuracy vs. 82.5% for LaBraM and 82.0% for BrainBERT. On the private XJSZ-SEEG detection dataset, it achieves 94.1% vs. 86.8% for LaBraM. The same pattern holds for prediction tasks (e.g., XJSZ-SEEG short-term MAE 0.5587 vs. 0.7556 for LaBraM). These margins are meaningful and consistent.

2. **Neural tokenizer trained jointly on both EEG and SEEG.** The paper explicitly notes (Section 2.3) that prior work like LaBraM trained the tokenizer only on EEG, making it incompatible with SEEG. EpilepsyFM's tokenizer is trained on both signal types, enabling a unified codebook for intracranial and extracranial signals. This is a concrete, practical contribution.

3. **Collection and use of a clinical SEEG dataset.** The paper collects time-locked SEEG data from 20 patients at a hospital, a data type that is scarce in the literature (the paper correctly notes the lack of public SEEG epilepsy datasets). This data is used for both pre-training and downstream evaluation.

4. **Ablation shows pre-training improves downstream performance.** Figure 5 demonstrates that removing pre-training causes a drop in both detection and prediction metrics across TUAB, CHB-MIT, and TUEV, confirming that the pre-training procedure as a whole contributes to performance.

## Weaknesses

### Fatal
None.

### Major

1. **Core methodological innovation (channel set masking) is not ablated.** The paper motivates channel set masking as the key design that "considers the mechanisms of epileptic seizures" (Section 2.4), but the only pre-training ablation (Section 4, Figure 5) compares *with vs. without any pre-training at all*. This tests pre-training in general, not the specific masking strategy. Without an ablation comparing channel set masking against standard random patch masking (as used in LaBraM and BrainBERT) at the same masking ratio, the contribution of the paper's central technical novelty is unevaluated. The reported gains could plausibly come from the encoder architecture, the joint EEG/SEEG tokenizer, or the transformer design rather than the masked modeling strategy.

2. **No variance estimates or statistical testing reported for any metric.** No standard deviations, confidence intervals, or per-fold results are provided for any downstream task. Given the modest sample sizes (e.g., 8 patients for private hospital evaluation) and known high inter-patient variability in epilepsy, the reported numerical advantages cannot be assessed for significance. It is also not specified whether the same train/validation/test splits were used across all baselines.

3. **Potential patient-level data leakage between pre-training and downstream TUH datasets is not addressed.** Pre-training uses TUEP, TUSL, and TUSZ from the TUH ecosystem, while downstream evaluation includes TUAB and TUEV from the same ecosystem. The paper states "different patients" for the private XJSZ data but provides no confirmation that the TUH patients are disjoint across pre-training and downstream splits. If overlapping patients exist, results would be artificially inflated.

4. **The "state-of-the-art" claim overreaches the baseline comparison.** The paper claims state-of-the-art performance across tasks but only compares against self-supervised EEG pre-training methods (TF-C, SimMTM, BrainBERT, LaBraM) and one supervised EEG transformer (ST-Transformer). It does not compare against any epilepsy-specific supervised methods (e.g., graph networks, CNN-transformer hybrids, or attention-based models that report strong results on CHB-MIT and TUH datasets). While comparing against foundation-model-style baselines is appropriate for a foundation model paper, the unqualified "SOTA" claim requires a broader set of comparators or at least explicit acknowledgment of which baselines are being compared.

### Minor

1. **Prediction task evaluation lacks clinically meaningful metrics.** The paper motivates signal prediction as enabling "early warning systems" (Section 3.6) but evaluates using only MAE and MSE on normalized signals. It does not report clinically relevant measures such as seizure onset detection latency, sensitivity/specificity of an early warning system built from predictions, or even a trivial baseline (e.g., persistence forecast). Whether a 0.64 MAE improvement translates to clinical benefit is unclear.

2. **Reliance on private data limits reproducibility of core results.** The model uses private clinical data (XJSZ-EEG, XJSZ-SEEG) for both pre-training and downstream evaluation. The most striking results (SEEG detection and prediction) come entirely from these private datasets. While this is not disqualifying, the paper does not state any code, model weight, or tokenizer release plan that would allow partial reproducibility on the public TUH/CHB-MIT data.

3. **No analysis of the neural tokenizer.** The paper trains an epilepsy-specific neural codebook but does not report: the number of codes ($N_{\text{code}}$), codebook perplexity, reconstruction error on DFT targets, or whether the tokenizer generalizes to held-out SEEG data. This makes it difficult to assess the quality of the learned representations.

4. **Missing experimental details.** The masking ratio $r$ is never specified. The pre-training data composition (relative proportions of TUH vs. private data) is not reported. Baseline implementation details are not described — it is unclear whether baselines were re-implemented, adapted from official repos, or fine-tuned from their public checkpoints.

### Trivial

1. **Notation inconsistency.** The paper uses $\odot$ for what it describes as concatenation ($\varepsilon p = \varepsilon_t \odot \varepsilon_w$ in Section 2.2), while using $\copyright$ for concatenation in the spectral encoder description. This is a minor but fixable issue.
2. **"Time-locked" data is mentioned but not explained** (Section 3.1). The term is used to describe the private dataset but never defined.

## Nice-to-Haves

- Ablate channel set masking against random patch masking at the same masking ratio on a single large dataset (e.g., TUAB or CHB-MIT).
- Add at least 2–3 epilepsy-specific supervised baselines to the comparison, or explicitly scope the claim to "outperforms self-supervised EEG pre-training methods."
- Report 5-fold cross-validation results or bootstrapped confidence intervals, and note whether the same splits were used across all methods.
- Explicitly confirm patient-level separation between pre-training and downstream splits for all TUH datasets.
- Add a trivial signal prediction baseline (e.g., persistence forecast: predict the last observed window).
- Include neural tokenizer diagnostics (codebook size, perplexity, reconstruction error).
- Release code and pre-trained model weights for the public data portion to enable partial reproducibility.

## Removed Points

These points are flagged for removal; treat them with caution.

- **Criticism that prediction task is unspecified (next-timestep vs. seizure prediction vs. reconstruction):** The paper clearly specifies the task in Section 3.6: "historical sequence length to 90 epochs (90 seconds), with short-term predictions covering 12 epochs (12 seconds) and long-term predictions spanning 20 epochs (20 seconds)." This is a forecasting task. The criticism is factually incorrect; removed.
- **Criticism that "the actual numbers in the tables are not readable":** This is a PDF-parser artifact. In the original submission, tables are rendered as images and are readable. Removed per parser-artifact rule.
- **Criticism about equations being "garbled":** The parsed text shows LaTeX rendering artifacts, not errors in the original paper. Removed per parser-artifact rule.
- **Criticism about the paper "does not cite multi-task epilepsy models" in the introduction:** This falls under the "missing related works" constraint. Removed.
- **Criticism about missing appendix content / proofs:** Parser strips appendices from all papers. Removed per parser-artifact rule.
- **Generic framing from the Strengthening the Paper on Its Own Terms section:** Those are suggestions for improvement, not weaknesses of the current submission. Moved to Nice-to-Haves where appropriate.
- **Weakness about "data leakage" with private data being same patients:** The paper explicitly states the XJSZ downstream data comes from "different patients" than the XJSZ pre-training data (line 163). The TUH data concern is retained as a separate Major weakness.

## Novel Insights

None beyond the paper's own contributions. The reviewer inputs did not surface an observation about the paper that the paper itself does not already articulate.

## Suggestions

1. **Add the channel set masking ablation.** This is the single most impactful addition: compare channel set masking (r=0.15, 0.30, 0.50) against random patch masking at the same ratios on a large public dataset. Report detection and prediction metrics. Without this, the paper's claimed novelty is a hypothesis, not a finding.
2. **Add error bars or cross-validation.** Even simple 5-fold results (mean ± std) for the main comparisons would substantially strengthen the claims.
3. **Address the TUH data leakage concern.** Explicitly state whether patients in TUEP/TUSL/TUSZ (pre-training) overlap with those in TUAB/TUEV (downstream), or note that these are distinct sub-collections and why they are guaranteed disjoint.
4. **Qualify the SOTA claim.** Replace "state-of-the-art" with "competitive with / outperforms self-supervised EEG pre-training methods" and clearly scope the comparison. Add at least one or two task-specific supervised methods to the comparison to support the broader SOTA claim.
5. **Report neural tokenizer statistics** — codebook size, reconstruction error, and codebook perplexity — to allow assessment of representation quality.
6. **Clarify the notation** in the spatial encoder section ($\odot$ vs. concatenation).

## Score and Decision

The paper addresses an important problem (epilepsy-specific foundation model handling both EEG and SEEG) and demonstrates consistent improvements over self-supervised baselines. However, the evaluation has multiple unresolved issues: the core methodological novelty (channel set masking) is not ablated, no variance estimates are provided, potential data leakage is unaddressed, and the SOTA claim overreaches the baseline comparison. These are not fatal — the paper's contributions are real — but they prevent the current version from being a convincingly supported submission.

MY FINAL SCORE: <score>5.0</score>
MY FINAL DECISION: <decision>Reject</decision>